194032-42-3 Usage
Description
TETRT-BUTYL5-METHYL-1,4-DIAZEPANE-1-CARBOXYLATE is a homopiperazine derivative with potential antibiotic properties and is utilized as a reagent in the preparation of CXCR4 receptor antagonists and isoquinoline derivatives of drugs, which have demonstrated biological activity.
Uses
Used in Pharmaceutical Industry:
TETRT-BUTYL5-METHYL-1,4-DIAZEPANE-1-CARBOXYLATE is used as a reagent for the synthesis of CXCR4 receptor antagonists, which are crucial in the development of drugs targeting various diseases, including certain types of cancer and immune disorders. Its role in this application is to facilitate the creation of these therapeutic agents by acting as a key component in their chemical structure.
Used in Drug Development:
TETRT-BUTYL5-METHYL-1,4-DIAZEPANE-1-CARBOXYLATE is also used as a reagent in the preparation of isoquinoline derivatives of drugs. These derivatives have shown biological activity, making them valuable in the development of new medications with potential applications in treating a range of health conditions.
Used in Antibiotic Research:
As a homopiperazine derivative, TETRT-BUTYL5-METHYL-1,4-DIAZEPANE-1-CARBOXYLATE holds potential as an antibiotic agent. It is used in the research and development of new antibiotics, which is essential in the ongoing fight against antibiotic resistance and the need for novel treatments to combat bacterial infections.
Check Digit Verification of cas no
The CAS Registry Mumber 194032-42-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,4,0,3 and 2 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 194032-42:
(8*1)+(7*9)+(6*4)+(5*0)+(4*3)+(3*2)+(2*4)+(1*2)=123
123 % 10 = 3
So 194032-42-3 is a valid CAS Registry Number.
InChI:InChI=1/C11H22N2O2/c1-9-5-7-13(8-6-12-9)10(14)15-11(2,3)4/h9,12H,5-8H2,1-4H3
194032-42-3Relevant articles and documents
CXCR4 Receptor Antagonists
-
Paragraph 0213; 0214, (2013/11/06)
Disclosed are compounds that are antagonists of the CXCR4 receptor.
